Efficiency of phage therapy in humans: systematic review

Successful implementation of lytic virulent bacteriophages in clinical practice requires convincing evidence of its safety and efficacy.Design: We searched in CENTRAL, MEDLINE, Embase, and Russian-language literature databases in May 2018. Original articles must fulfill the following eligibility cri...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Saperkin, O. V. Kovalishena, D. V. Kvashnina, E. Ruizendaal, R. Scholten
Format: Article
Language:Russian
Published: Journal Infectology 2019-12-01
Series:Журнал инфектологии
Subjects:
Online Access:https://journal.niidi.ru/jofin/article/view/957
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849398778400866304
author N. V. Saperkin
O. V. Kovalishena
D. V. Kvashnina
E. Ruizendaal
R. Scholten
author_facet N. V. Saperkin
O. V. Kovalishena
D. V. Kvashnina
E. Ruizendaal
R. Scholten
author_sort N. V. Saperkin
collection DOAJ
description Successful implementation of lytic virulent bacteriophages in clinical practice requires convincing evidence of its safety and efficacy.Design: We searched in CENTRAL, MEDLINE, Embase, and Russian-language literature databases in May 2018. Original articles must fulfill the following eligibility criteria: randomized, controlled trials investigating the effects of phage therapy in people with bacterial infections; at least one patient outcome was reported. Three review authors independently selected, studies, extracted, data, and. assessed, risk of bias. We used, random-effects models for meta-analysis.Participants: adults and. children of both, sexes with bacterial infection, including multi-drug resistant variants, or individuals at risk of infection.Outcomes: recovery or resolution of infection; clinical improvement; change in number of exacerbations; recurrence of infection; quality of life; elimination or load, reduction of a pathogen in an anatomical compartment.Results: We included 13 trials (issued in 1965-2018) including 9 treatment studies and. 4 prevention studies. Overall, eight randomized, trials involved, adults. Five studies addressed skin and soft tissues infections, six studies concerned intestinal infections, one study addressed respiratory tract infection and. one study — ear infection. Across bias domains, 35-90% of trials scored, low risk of bias. Meta-analysis for adverse events attributable to phages and. for wound, healing provided us with pooled relative risks of 0.74 (95% CI 0.68;1.2) and 0.91 (95% CI0.68;1.2) respectively.Conclusions: Beneficial effect of bacteriophages can be demonstrated, and. not refuted. However, our study led. to tentative conclusions. The conduct of well-designed and sufficiently powered, trials would, facilitate registration and. wide accepting of bacteriophage treatment.
format Article
id doaj-art-b61fe7fc06de45fe803c0d9ffb27b1e2
institution Kabale University
issn 2072-6732
language Russian
publishDate 2019-12-01
publisher Journal Infectology
record_format Article
series Журнал инфектологии
spelling doaj-art-b61fe7fc06de45fe803c0d9ffb27b1e22025-08-20T03:38:30ZrusJournal InfectologyЖурнал инфектологии2072-67322019-12-01114193010.22625/2072-6732-2019-11-4-19-30757Efficiency of phage therapy in humans: systematic reviewN. V. Saperkin0O. V. Kovalishena1D. V. Kvashnina2E. Ruizendaal3R. Scholten4Privolzhskiy Research Medical UniversityPrivolzhskiy Research Medical UniversityPrivolzhskiy Research Medical UniversityUtrecht UniversityUtrecht University, Cochrane Netherlands, University Medical CenterSuccessful implementation of lytic virulent bacteriophages in clinical practice requires convincing evidence of its safety and efficacy.Design: We searched in CENTRAL, MEDLINE, Embase, and Russian-language literature databases in May 2018. Original articles must fulfill the following eligibility criteria: randomized, controlled trials investigating the effects of phage therapy in people with bacterial infections; at least one patient outcome was reported. Three review authors independently selected, studies, extracted, data, and. assessed, risk of bias. We used, random-effects models for meta-analysis.Participants: adults and. children of both, sexes with bacterial infection, including multi-drug resistant variants, or individuals at risk of infection.Outcomes: recovery or resolution of infection; clinical improvement; change in number of exacerbations; recurrence of infection; quality of life; elimination or load, reduction of a pathogen in an anatomical compartment.Results: We included 13 trials (issued in 1965-2018) including 9 treatment studies and. 4 prevention studies. Overall, eight randomized, trials involved, adults. Five studies addressed skin and soft tissues infections, six studies concerned intestinal infections, one study addressed respiratory tract infection and. one study — ear infection. Across bias domains, 35-90% of trials scored, low risk of bias. Meta-analysis for adverse events attributable to phages and. for wound, healing provided us with pooled relative risks of 0.74 (95% CI 0.68;1.2) and 0.91 (95% CI0.68;1.2) respectively.Conclusions: Beneficial effect of bacteriophages can be demonstrated, and. not refuted. However, our study led. to tentative conclusions. The conduct of well-designed and sufficiently powered, trials would, facilitate registration and. wide accepting of bacteriophage treatment.https://journal.niidi.ru/jofin/article/view/957bacteriophagetherapyprophylaxisbacterial infectionsystematic reviewmeta-analysisbiaswoundadverse event
spellingShingle N. V. Saperkin
O. V. Kovalishena
D. V. Kvashnina
E. Ruizendaal
R. Scholten
Efficiency of phage therapy in humans: systematic review
Журнал инфектологии
bacteriophage
therapy
prophylaxis
bacterial infection
systematic review
meta-analysis
bias
wound
adverse event
title Efficiency of phage therapy in humans: systematic review
title_full Efficiency of phage therapy in humans: systematic review
title_fullStr Efficiency of phage therapy in humans: systematic review
title_full_unstemmed Efficiency of phage therapy in humans: systematic review
title_short Efficiency of phage therapy in humans: systematic review
title_sort efficiency of phage therapy in humans systematic review
topic bacteriophage
therapy
prophylaxis
bacterial infection
systematic review
meta-analysis
bias
wound
adverse event
url https://journal.niidi.ru/jofin/article/view/957
work_keys_str_mv AT nvsaperkin efficiencyofphagetherapyinhumanssystematicreview
AT ovkovalishena efficiencyofphagetherapyinhumanssystematicreview
AT dvkvashnina efficiencyofphagetherapyinhumanssystematicreview
AT eruizendaal efficiencyofphagetherapyinhumanssystematicreview
AT rscholten efficiencyofphagetherapyinhumanssystematicreview